Options
Favorable response to erlotinib in a lung adenocarcinoma with both EGFR exon-19 deletion and K-ras G13D mutations
Type
report
Resource
Lee CN, Chen HY, Liu HE(2010).Favorable response to erlotinib in a lung adenocarcinoma with both EGFR exon-19 deletion and K-ras G13D mutations. Journal of Clinical Oncology.(28):111-112.
Date Issued
2010
Author(s)
CN, Lee;HY, Chen;HE, Liu
Subjects
藥學系
計畫報告